RAFAEL HOLDINGS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
RAFAEL HOLDINGS, INC. (RFL) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$10.82 million for the 12-month period ending 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2024-07-31 was -$1.87M, a 125.30% decline year-over-year.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2024-04-30 was $631.00K, a 91.46% decline year-over-year.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2024-01-31 was -$2.79M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2023-10-31 was -$6.79M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2024 was -$10.82M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2023 was -$26.96M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2022 was -$63.68M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2021 was -$7.92M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2024-07-31 | -$1.87M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$1.24M derived: sum of 2 quarters · filed 2024-12-20 | -$4.03M derived: sum of 3 quarters · filed 2024-12-20 | -$10.82M 10-K/A · filed 2024-12-20 | |
| 2024-04-30 | $631.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | -$2.16M derived: sum of 2 quarters · filed 2024-06-14 | -$8.95M 10-Q · filed 2024-06-14 | -$1.54M derived: sum of 4 quarters · filed 2024-12-20 | |
| 2024-01-31 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | -$9.58M 10-Q · filed 2024-03-14 | -$2.17M derived: sum of 3 quarters · filed 2024-12-20 | $5.22M derived: sum of 4 quarters · filed 2024-12-20 | |
| 2023-10-31 | -$6.79M 10-Q · filed 2023-12-14 | $621.00K derived: sum of 2 quarters · filed 2024-12-20 | $8.01M derived: sum of 3 quarters · filed 2024-12-20 | $451.00K derived: sum of 4 quarters · filed 2024-12-20 | |
| 2023-07-31 | $7.41M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $14.79M derived: sum of 2 quarters · filed 2024-12-20 | $7.24M derived: sum of 3 quarters · filed 2024-12-20 | -$26.96M 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | $7.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | -$170.00K derived: sum of 2 quarters · filed 2024-06-14 | -$34.37M 10-Q · filed 2024-06-14 | -$40.72M derived: sum of 4 quarters · filed 2024-06-14 | |
| 2023-01-31 | -$7.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | -$41.75M 10-Q · filed 2024-03-14 | -$48.10M derived: sum of 3 quarters · filed 2024-03-14 | -$78.56M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-10-31 | -$34.20M 10-Q · filed 2023-12-14 | -$34.23M 10-Q · filed 2022-12-13 | -$40.55M derived: sum of 2 quarters · filed 2023-12-14 | -$71.00M derived: sum of 3 quarters · filed 2023-12-14 | -$71.00M derived: sum of 4 quarters · filed 2023-12-14 |
| 2022-07-31 | -$6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | -$36.81M derived: sum of 2 quarters · filed 2023-10-30 | -$36.81M derived: sum of 3 quarters · filed 2023-10-30 | -$63.68M 10-K · filed 2023-10-30 | |
| 2022-04-30 | -$30.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$30.46M derived: sum of 2 quarters · filed 2023-06-13 | -$57.33M 10-Q · filed 2023-06-13 | ||
| 2022-01-31 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$26.88M 10-Q · filed 2023-03-14 | |||
| 2021-10-31 | -$26.88M 10-Q · filed 2022-12-13 | ||||
| 2021-07-31 | -$7.92M 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |